Oppenheimer & CO Inc Repligen Corp Transaction History

Oppenheimer & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $839,961 - $1.34 Million	-5,211 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$247.59 - $304.47 $1.12 Million - $1.38 Million	4,519 Added 653.03%	5,211 $1.38 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $305,009 - $507,712	-1,566 Reduced 69.35%	692 $200,000
Q2 2021 Aug 03, 2021	SELL	$165.87 - $220.95 $573,412 - $763,824	-3,457 Reduced 60.49%	2,258 $451,000
Q1 2021 May 10, 2021	BUY	$180.37 - $226.26 $555,900 - $697,333	3,082 Added 117.05%	5,715 $1.11 Million
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $389,894 - $543,898	2,633 New	2,633 $504,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.